Immunic AG | WebDisclosure

Switch to English

9804	Sociétés
196632	Mots-clés
127649	Articles
104544	Communiqués

Accueil
Sociétés
Immunic AG

COMMUNIQUÉ DE PRESSE

publié le 25/09/2025 à 12:30, il y a 4 mois 9 jours

Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis
Immunic presented key Vidofludimus Calcium data at the 41st Congress of ECTRIMS, highlighting its potential in multiple sclerosis. The data underscore its neuroprotective potential and promise to slow disease progression

Multiple Sclerosis Immunic Vidofludimus Calcium ECTRIMS Congress Neuroprotective Potential
BRÈVE

publiée le 09/09/2025 à 12:35, il y a 4 mois 25 jours

Immunic obtient un brevet américain pour le vidofludimus calcique dans le traitement de la sclérose en plaques

Sclérose En Plaques Essai De Phase 2 Immunique Vidofludimus Calcique Allocation De Brevet
BRÈVE

publiée le 09/09/2025 à 12:35, il y a 4 mois 25 jours

Immunic Secures U.S. Patent for Vidofludimus Calcium in Multiple Sclerosis

Multiple Sclerosis Immunic Vidofludimus Calcium Phase 2 Trial Patent Allowance
COMMUNIQUÉ DE PRESSE

publié le 09/09/2025 à 12:30, il y a 4 mois 25 jours

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis
Immunic receives United States Patent Notice of Allowance for Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis, extending protection into 2041

United States Patent Immunic Vidofludimus Calcium Progressive Multiple Sclerosis Patent Notice Of Allowance
BRÈVE

publiée le 04/09/2025 à 12:35, il y a 5 mois

Immunic Announces Participation in Key Conferences

Immunic Vidofludimus Calcium Investor Meetings Biopharma Conference ECTRIMS 2025
BRÈVE

publiée le 04/09/2025 à 12:35, il y a 5 mois

Immunic annonce sa participation à des conférences clés

Réunions D'investisseurs Immunique Vidofludimus Calcique ECTRIMS 2025 Conférence Biopharmaceutique
COMMUNIQUÉ DE PRESSE

publié le 04/09/2025 à 12:30, il y a 5 mois

Immunic to Participate in Investor and Scientific Conferences in September
Immunic, Inc. (Nasdaq: IMUX) to participate in investor and scientific conferences in September, including H.C. Wainwright 27th Annual Global Investment Conference and ECTRIMS Congress

Investor Conference Clinical Pipeline Scientific Conference Immunic Inc ECTRIMS Congress
BRÈVE

publiée le 07/08/2025 à 12:35, il y a 5 mois 28 jours

Immunic Reports Q2 2025 Financial Results with Vidofludimus Calcium Progress

Vidofludimus Calcium Multiple Sclerosis Trials R&D Expenses Biotech Investment Immunic Financial Results
BRÈVE

publiée le 07/08/2025 à 12:35, il y a 5 mois 28 jours

Immunic publie ses résultats financiers du deuxième trimestre 2025 avec les progrès du Vidofludimus Calcium

Essais Sur La Sclérose En Plaques Dépenses De R&D Vidofludimus Calcique Résultats Financiers D'Immunic Investissement Dans Les Biotechnologies
COMMUNIQUÉ DE PRESSE

publié le 07/08/2025 à 12:30, il y a 5 mois 28 jours

Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports positive Q2 2025 results with focus on clinical progress of vidofludimus calcium for multiple sclerosis treatment

Clinical Trials Immunic Inc. Multiple Sclerosis Vidofludimus Calcium Q2 2025 Results

Les Echos

Publié le 04/02/2026 à 18:04, il y a 3 heures 48 minutes

Capital et droits de vote au 31 janvier 2026
Publié le 04/02/2026 à 18:04, il y a 3 heures 48 minutes

Total number of voting rights and shares making up the share capital at January 31, 2026
Publié le 04/02/2026 à 17:45, il y a 4 heures 7 minutes

Information concerning the total number of voting rights and shares 2026 01 31
Publié le 04/02/2026 à 17:45, il y a 4 heures 7 minutes

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Publié le 04/02/2026 à 17:45, il y a 4 heures 7 minutes

Janvier 2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 04/02/2026 à 18:00, il y a 3 heures 52 minutes

Lithium South AGSM Update
Publié le 04/02/2026 à 16:15, il y a 5 heures 37 minutes

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Publié le 04/02/2026 à 15:45, il y a 6 heures 7 minutes

Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Publié le 04/02/2026 à 15:00, il y a 6 heures 52 minutes

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Publié le 04/02/2026 à 14:30, il y a 7 heures 22 minutes

Datametrex Expands Business In Data Centres

Voir tout ACCESSWIRE

EQS Group

Publié le 04/02/2026 à 20:54, il y a 58 minutes

Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Publié le 04/02/2026 à 20:36, il y a 1 heure 16 minutes

EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Publié le 04/02/2026 à 20:00, il y a 1 heure 51 minutes

Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Publié le 04/02/2026 à 18:55, il y a 2 heures 57 minutes

Funding Circle Holdings plc: POS-Transaction in Own Shares
Publié le 04/02/2026 à 18:40, il y a 3 heures 11 minutes

Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology